Explore the Agenda

8:00 am Check-In & Morning Coffee

8:50 am Chair’s Opening Remarks

Advancing Standardization Across Processes, Systems, & Technologies to Enable Efficiency, Interoperability, & Scalable Operations

9:00 am Embedding Standards Early in the Process for Optimal Compliance

Director - Technical, ICCBBA
  •  Explore emerging scenarios for extending chain of identity (CoI) beyond autologous therapies to support commercial and off-the-shelf models and streamline end-to-end services
  • Examine how accrediting bodies evolve requirements from “should” to “shall”, and what that shift means for sustained compliance over time
  • Identify future proofing strategies for applying chain of identity identifiers across systems

9:30 am ucing Operational Complexity at Sites & Treatment Centres for HighQuality, Reliable Care

Senior Director of Quality & Compliance, Vyriad
  •  Minimizing variability in packing, documentation, and procedures to lower training burdens, reduce liability, and decrease error risk
  • Standardizing chain of identity and chain of custody practices to improve interoperability across sponsors, logistics providers, and clinical sites
  • Designing processes around patient and site realities with clearer, more consistent expectations for storage, transportation, and digital workflows

10:00 am Maximizing Impact by Balancing Innovation, Budget, & Technology for Sustainable Growth

Senior Manager, Procurement, Immatics Gmbh
  •  Prioritizing therapeutic innovation while allocating resources effectively to support digital and operational needs
  • Managing technology and software adoption costs to ensure optimal performance and return on investment
  • Guiding emerging biotechs to stretch limited funds effectively while fostering innovation

10:30 am Morning Break & Speed Networking Session

Streamlining Fragmented Digital Workflows & Portals to Enhance Communication, Reduce Administrative Burden, & Improve End-to-End Coordination

11:30 am Enabling Interoperability at Scale to Facilitate Standardization Without Uniformity

Deputy Technical Director, ICCBBA
  • Enabling interoperability while preserving internal agility and innovation to maintain competitive differentiation and accelerate growth
  • Standardizing data structures and communication to eliminate silos, streamline operations, and reduce costs
  • Reducing complexity from inconsistent packing, documentation, and checklists to improve efficiency, reliability, and scalability

12:00 pm Panel: Confronting Portal Fragmentation to Accelerate Workflows & Enable Faster, More Connected Care

Director - Technical, ICCBBA
Senior Director of Quality & Compliance, Vyriad
Associate Director, Supply Chain Category Management, Sana Biotechnology
  • Adopting hub or network-based models to reduce portal fatigue whilst accommodating site-specific operations
  • Providing shared visibility across logistics, manufacturing, and clinics to support compressed vein-to-vein timelines (<14 days) and accelerate therapy delivery
  • Leveraging commercially available digital tools for adoption in new and community-based sites

12:45 pm Lunch Break & Networking

Streamlining Workflows & Global Distribution to Manufacture Allogeneic Therapies at Scale

1:45 pm nufacturing Allogeneic Therapies at Scale to Deliver Reliable MultiPatient Supply

Senior Manager - Supply Chain Process Management, Bristol Myers Squibb
  •  Standardizing allogeneic manufacturing workflows to reduce variability and enable reproducible, multi-patient production
  • Optimizing cryopreservation strategies to maintain cell viability during long-term store and ensure reliable global distribution
  • Automating upstream and downstream workflows to increase output, reduce manual intervention, and control manufacturing costs

2:15 pm Panel: Addressing the Issues for Allogeneic & Off-the-Shelf Products to Support Scalable, Global Deployment

Executive Vice President, Vyriad
Cell & Gene Therapy, Patient Operations Manager, Genentech
Senior Manager - Supply Chain Process Management, Bristol Myers Squibb
  •  Navigating regional regulatory expectations for labelling, traceability, and product handling to ensure compliance and minimize regional risk
  • Aligning clinical, manufacturing, and supply chain teams to support rapid deployment of off-the-shelf products
  • Harmonizing global regulations shaped by autologous paradigms with the realities of allogeneic therapies to facilitate scalability

3:00 pm Afternoon Break & Networking

Optimizing Collaboration Across the Supply Chain for Reliable, Cost-Effective, & Scalable Performance

3:30 pm Panel Discussion: Cross-Collaboration Across the CGT Supply Chain for Improved Connectivity

Manager, Clinical Operations & Logistics, Kite Pharma Inc
Director - Supply Chain Patient Experience, ProKidney
Senior Director - Strategy, Business Operations & Clinical Supply Chain, Bristol Myers Squibb
Manager, Bloody & Marrow Transplant Laboratory, Clinical Trial & Commercial Product Handling Team, Moffitt Cancer Center
  • Navigating last mile logistics to support coordination between providers, couriers, and healthcare providers and ensure timely therapy delivery
  • Optimizing packaging, labelling, and cold-chain procedures to enhance efficiency, maintain safety, and ensure regulatory compliance
  • Engaging regulators, CROs, CDMOs, and logistics partners to align expectations, reduce delays, and strengthen end-toend connectivity

4:15 pm Supporting Early-Stage CGT Companies to Accelerate Global Growth & Market Readiness

Senior Director - Patient Operations, Abeona Therapeutics
  • Facilitating technology transfer, platform standardization, and manufacturing scale-up to attain clinical and commercial readiness and enable faster market entry
  • Building strategic partnerships and networks to reduce risk, shorten timelines, and improve access to global markets
  • Guiding small biotech teams through the complex regulatory landscape to ensure compliance and progression toward commercialization

4:45 pm Chair’s Closing Remarks